Cargando…
Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
BACKGROUND: Incidence of local relapse after definitive chemoradiation (>59 Gy) for locally advanced non-small-cell lung cancer (NSCLC) is high, irrespective of high dose radiation applied. Experience with salvage lung resections in patients with locally relapsed NSCLC after definitive chemoradia...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717585/ https://www.ncbi.nlm.nih.gov/pubmed/26781697 http://dx.doi.org/10.1186/s13019-016-0396-0 |
_version_ | 1782410678226649088 |
---|---|
author | Schreiner, Waldemar Dudek, Wojciech Lettmaier, Sebastian Fietkau, Rainer Sirbu, Horia |
author_facet | Schreiner, Waldemar Dudek, Wojciech Lettmaier, Sebastian Fietkau, Rainer Sirbu, Horia |
author_sort | Schreiner, Waldemar |
collection | PubMed |
description | BACKGROUND: Incidence of local relapse after definitive chemoradiation (>59 Gy) for locally advanced non-small-cell lung cancer (NSCLC) is high, irrespective of high dose radiation applied. Experience with salvage lung resections in patients with locally relapsed NSCLC after definitive chemoradiation is limited. We present our series of salvage lung resections for local NSCLC relapse after curative–intent chemoradiation for locally advanced tumor. METHODS: Nine consecutive patients with local tumor recurrence or persistence following definitive chemoradiation were reviewed. Kaplan-Meier analysis was used to assess patient survival. RESULTS: All patients received definitive radiation (median dose 66.2 Gy) with concurrent chemotherapy. Tumor stage prior to chemoradiation was IIIA in 8 patients and IV in 1. In 4 patients tumor invaded the chest wall, in 2 the spine and in 1 the aorta. Median interval between chemoradiation and salvage resection was 30.2 weeks. Nine patients underwent 9 resections (6 lobectomies, 1 bilobectomy, 1 pneumonectomy and 1 bi-segmentectomy). One death occurred on the 12th postoperative day. Median overall survival was 23 months; postoperative 3-year survival was 47 %. Median progression-free survival was 21 months. CONCLUSION: Salvage lung resection for locally recurrent or persisted NSCLC in selected patients with locally advanced NSCLC following definitive chemoradiation is a worthwhile treatment option. |
format | Online Article Text |
id | pubmed-4717585 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47175852016-01-20 Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer? Schreiner, Waldemar Dudek, Wojciech Lettmaier, Sebastian Fietkau, Rainer Sirbu, Horia J Cardiothorac Surg Research Article BACKGROUND: Incidence of local relapse after definitive chemoradiation (>59 Gy) for locally advanced non-small-cell lung cancer (NSCLC) is high, irrespective of high dose radiation applied. Experience with salvage lung resections in patients with locally relapsed NSCLC after definitive chemoradiation is limited. We present our series of salvage lung resections for local NSCLC relapse after curative–intent chemoradiation for locally advanced tumor. METHODS: Nine consecutive patients with local tumor recurrence or persistence following definitive chemoradiation were reviewed. Kaplan-Meier analysis was used to assess patient survival. RESULTS: All patients received definitive radiation (median dose 66.2 Gy) with concurrent chemotherapy. Tumor stage prior to chemoradiation was IIIA in 8 patients and IV in 1. In 4 patients tumor invaded the chest wall, in 2 the spine and in 1 the aorta. Median interval between chemoradiation and salvage resection was 30.2 weeks. Nine patients underwent 9 resections (6 lobectomies, 1 bilobectomy, 1 pneumonectomy and 1 bi-segmentectomy). One death occurred on the 12th postoperative day. Median overall survival was 23 months; postoperative 3-year survival was 47 %. Median progression-free survival was 21 months. CONCLUSION: Salvage lung resection for locally recurrent or persisted NSCLC in selected patients with locally advanced NSCLC following definitive chemoradiation is a worthwhile treatment option. BioMed Central 2016-01-19 /pmc/articles/PMC4717585/ /pubmed/26781697 http://dx.doi.org/10.1186/s13019-016-0396-0 Text en © Schreiner et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Schreiner, Waldemar Dudek, Wojciech Lettmaier, Sebastian Fietkau, Rainer Sirbu, Horia Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer? |
title | Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer? |
title_full | Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer? |
title_fullStr | Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer? |
title_full_unstemmed | Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer? |
title_short | Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer? |
title_sort | should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717585/ https://www.ncbi.nlm.nih.gov/pubmed/26781697 http://dx.doi.org/10.1186/s13019-016-0396-0 |
work_keys_str_mv | AT schreinerwaldemar shouldsalvagesurgerybeconsideredforlocalrecurrenceafterdefinitivechemoradiationinlocallyadvancednonsmallcelllungcancer AT dudekwojciech shouldsalvagesurgerybeconsideredforlocalrecurrenceafterdefinitivechemoradiationinlocallyadvancednonsmallcelllungcancer AT lettmaiersebastian shouldsalvagesurgerybeconsideredforlocalrecurrenceafterdefinitivechemoradiationinlocallyadvancednonsmallcelllungcancer AT fietkaurainer shouldsalvagesurgerybeconsideredforlocalrecurrenceafterdefinitivechemoradiationinlocallyadvancednonsmallcelllungcancer AT sirbuhoria shouldsalvagesurgerybeconsideredforlocalrecurrenceafterdefinitivechemoradiationinlocallyadvancednonsmallcelllungcancer |